20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia / Jari Tiihonen en The American Journal of Psychiatry, Año 2018 - Vol. 175 - No. 8 (Agosto)

Público ISBD [artículo]  inThe American Journal of Psychiatry > Año 2018 - Vol. 175 - No. 8 (Agosto) . - pp. 765-773 Título : 20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia Tipo de documento: texto impreso Autores: Jari Tiihonen, Autor ; Antti Tanskanen, Autor ; Heidi Taipale, Autor Fecha de publicación: 2018 Artículo en la página: pp. 765-773 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicótico, Hospitalización, Recaída, Esquizofrenia - primer episodio Resumen: It is generally believed that after the first episode of schizophrenia, the risk of relapse decreases with time in patients who are stabilized. Many treatment guidelines recommend that after stabilization, antipsychotic treatment should be continued for 1-5 years, and longer exposure should be avoided if possible. Link: ./index.php?lvl=notice_display&id=17665 [artículo] 20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia [texto impreso] / Jari Tiihonen, Autor ; Antti Tanskanen, Autor ; Heidi Taipale, Autor . - 2018 . - pp. 765-773. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The American Journal of Psychiatry > Año 2018 - Vol. 175 - No. 8 (Agosto) . - pp. 765-773 Palabras clave: Antipsicótico, Hospitalización, Recaída, Esquizofrenia - primer episodio Resumen: It is generally believed that after the first episode of schizophrenia, the risk of relapse decreases with time in patients who are stabilized. Many treatment guidelines recommend that after stabilization, antipsychotic treatment should be continued for 1-5 years, and longer exposure should be avoided if possible. Link: ./index.php?lvl=notice_display&id=17665

Safety of antipsychotic polypharmacy versus monotherapy in a nationwide cohort of 61,889 patients with schizophrenia / Heidi T. Taipale en The American Journal of Psychiatry, Año 2023 - Vol. 180 - No. 5 (Mayo)

Público ISBD [artículo]  inThe American Journal of Psychiatry > Año 2023 - Vol. 180 - No. 5 (Mayo) . - pp. 377-385 Título : Safety of antipsychotic polypharmacy versus monotherapy in a nationwide cohort of 61,889 patients with schizophrenia Tipo de documento: texto impreso Autores: Heidi T. Taipale, Autor ; Antti J. Tanskanen, Autor ; Jari Tiihonen, Autor Fecha de publicación: 2023 Artículo en la página: pp. 377-385 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Polifarmacia, Espectro de esquizofrenia, Trastornos psicóticos Resumen: The authors sought to study the safety of antipsychotic polypharmacy compared with monotherapy in specific dosage categories. Patients with schizophrenia (N=61,889; median follow-up, 14.8 years [IQR=7.4–22.0]) were identified from the Finnish nationwide inpatient care register and followed up over the period 1996–2017. Link: ./index.php?lvl=notice_display&id=29988 [artículo] Safety of antipsychotic polypharmacy versus monotherapy in a nationwide cohort of 61,889 patients with schizophrenia [texto impreso] / Heidi T. Taipale, Autor ; Antti J. Tanskanen, Autor ; Jari Tiihonen, Autor . - 2023 . - pp. 377-385. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The American Journal of Psychiatry > Año 2023 - Vol. 180 - No. 5 (Mayo) . - pp. 377-385 Palabras clave: Antipsicóticos, Polifarmacia, Espectro de esquizofrenia, Trastornos psicóticos Resumen: The authors sought to study the safety of antipsychotic polypharmacy compared with monotherapy in specific dosage categories. Patients with schizophrenia (N=61,889; median follow-up, 14.8 years [IQR=7.4–22.0]) were identified from the Finnish nationwide inpatient care register and followed up over the period 1996–2017. Link: ./index.php?lvl=notice_display&id=29988

---

1 (1 - 2 / 2)